Concepedia

Antoine Hommais

AH

Statistics

Publications

7

Citations

259

H-Index

7

Active since

2005

Affiliations

Inserm(Current)

University of Sheffield

Université Paris-Sud

Institut National du Cancer

Columbia University

Antoine Hommais is an author at Inserm specializing in human genetics, genetics, and genetic disorders.

Publications per year

2005–2023

7

Publications

7

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study

Jeroen Eikenboom, Lysiane Hilbert, Anne‐Sophie Ribba et al. · Journal of Thrombosis and Haemostasis · 2009 · 61 citations

Life Sciences, Genetics, Molecular Genetics +13

Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS‐13

Julie Rayes, Antoine Hommais, Paulette Legendre et al. · Journal of Thrombosis and Haemostasis · 2007 · 52 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance

Christina Yap, Olga Solovyeva, Johann S. de Bono et al. · BMJ · 2023 · 47 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +12

Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)

Antoine Hommais, Julie Rayes, Anne Houllier et al. · Thrombosis and Haemostasis · 2007 · 35 citations

Life Sciences, Genetics, Molecular Biology +11

Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance

Christina Yap, Jan Rekowski, Moreno Ursino et al. · BMJ · 2023 · 26 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +9

1–5 of 7